A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study.

BMC Infect Dis 2016 Sep 22;16(1):502. Epub 2016 Sep 22.

Department of Infectious Diseases Research and Prevention, Public Health Service of Amsterdam (GGD), Nieuwe Achtergracht 100, Amsterdam, 1018 WT, The Netherlands.

Background: Acquisition of genital human papillomavirus (HPV) infection is common among the young, sexually active population. Genital HPV infections do not always lead to seroconversion. We aimed to assess the association between cervico-vaginal high risk (hr) HPV DNA and type-specific antibodies in an ethnically diverse cohort of young women.

Methods: Women of Dutch, South-Asian Surinamese, African Surinamese, Ghanaian, Moroccan and Turkish origin participating in a large-scale multi-ethnic population-based cohort (the HELIUS study) provided vaginal self-samples and blood samples, and completed a questionnaire regarding demographics, lifestyle and sexual health. Vaginal swabs were tested for HPV using the highly sensitive SPF10-PCR DEIA/LiPA25 system (version1). Serum samples were tested for type-specific L1 antibodies against 7 hrHPV types (16,18,31,33,45,52,58) with multiplex serology. We assessed the association between vaginal HPV DNA and type-specific seropositivity with logistic and linear regression, using generalized estimating equations (GEE). We determined whether this association varies by ethnicity by adding an interaction term.

Results: We selected 532 women who completed the questionnaire, provided a vaginal swab and a blood sample. Their median age was 27 years (interquartile range 24-31 years). Prevalence of DNA of any of the 7 hrHPV was 22 %; HPV-52 was most common. Prevalence of antibodies against one or more hrHPV types was 24 %; HPV-16 seropositivity was most common. In multivariable logistic regression analysis using GEE, adjusting for other determinants, vaginal HPV DNA detection was associated with type-specific HPV seropositivity (OR 1.53, 95 % CI 1.06-2.20). In multivariable linear regression analysis using GEE, the geometric mean of type-specific antibody reactivity was 1.15 (95 % CI 1.04-1.27) times higher in women positive for HPV DNA compared to HPV DNA-negative women. There was little evidence that ethnicity modified the association between HPV DNA, and type-specific seropositivity, or with antibody reactivities (p = 0.47 and p = 0.57, respectively).

Conclusions: In this multi-ethnic group of young women in Amsterdam, cervico-vaginal hrHPV DNA detection was an independent determinant of type-specific HPV seropositivity.

Download full-text PDF

Source
http://bmcinfectdis.biomedcentral.com/articles/10.1186/s1287
Publisher Site
http://dx.doi.org/10.1186/s12879-016-1832-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034434PMC
September 2016
4 Reads

Publication Analysis

Top Keywords

hpv dna
24
vaginal hpv
12
dna detection
12
type-specific antibodies
12
hpv
12
dna type-specific
12
provided vaginal
8
helius study
8
antibodies hrhpv
8
analysis gee
8
hrhpv types
8
type-specific hpv
8
regression analysis
8
hpv seropositivity
8
linear regression
8
type-specific seropositivity
8
women amsterdam
8
completed questionnaire
8
type-specific
8
dna
8

References

(Supplied by CrossRef)

KG Keppel et al.
Public Health Rep 2010

C Martel de et al.
Lancet Oncol 2012

M Arnold et al.
Eur J Public Health 2013

JJ Carter et al.
J Infect Dis 2000

GY Ho et al.
Cancer Epidemiol Biomarkers Prev 2004

J Steele et al.
Clin Vaccine Immunol 2008

U Jaisamrarn et al.
PloS One 2013

RP Viscidi et al.
J Infect Dis 2003

HJ Vriend et al.
PloS One 2013

AE Paaso et al.
J Gen Virol 2011

FA Castro et al.
BMC Infect Dis 2014

Similar Publications